menu
    • menu

    Company profile for Actimed Therapeutics

    NEW Drugs in Dev.: 5
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are focused on bringing innovation to the treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider. Cachexia is a wasting disease that accompanies cancer and other serious chronic illnesses and is associated with significant morbidity and mortality...
    We are focused on bringing innovation to the treatment of cachexia with a vision to transform care for an under-served and vulnerable patient population, prolong and improve the quality of their lives, restore their dignity and ease the burden for the patient, carer and provider. Cachexia is a wasting disease that accompanies cancer and other serious chronic illnesses and is associated with significant morbidity and mortality. Despite its prevalence and devastating clinical effects, there is no approved drug for the treatment or prevention of cancer-related cachexia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Actimed Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    The Old Bakehouse, Course Road, Ascot, Berkshire, SL5 7HL.
    Telephone
    Telephone
    10519588
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://actimedtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Actimed Therapeutics Showcases Clinical Pipeline Progress
    Actimed Therapeutics Showcases Clinical Pipeline Progress

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202077/0/en/Actimed-Therapeutics-to-Highlight-Advancing-Clinical-Pipeline-with-New-Data-Presentations-at-18th-Annual-Conference-on-Sarcopenia-Cachexia-and-Wasting-Disorders.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Mankind Pharma Signs Licensing Deal With Actimed For Cachexia
    Mankind Pharma Signs Licensing Deal With Actimed For Cachexia

    22 Nov 2025

    // PRESS RELEASE

    https://www.mankindpharma.com/media/press-release/actimed-therapeutics-announces-important-licensing-agreement-with-mankind-pharma/

    PRESS RELEASE
    22 Nov 2025
    Share Share
    Actimed Begins Ph2a Study of S-pindolol in Obese Patients
    Actimed Begins Ph2a Study of S-pindolol in Obese Patients

    25 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/25/3104816/0/en/Actimed-Therapeutics-Enrolls-First-Patients-in-Phase-2a-PROACT-Study-Programme-to-Assess-S-pindolol-benzoate-in-Obese-Patients-During-and-Post-GLP-1-Agonist-Therapy.html

    GLOBENEWSWIRE
    25 Jun 2025
    Share Share
    Actimed Tests S-pindolol to Fight Muscle Loss in Obese Patients
    Actimed Tests S-pindolol to Fight Muscle Loss in Obese Patients

    20 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/20/3084550/0/en/Actimed-Therapeutics-Announces-New-Programme-to-Investigate-Potential-Muscle-Preservation-Effects-of-S-pindolol-Benzoate-in-Obese-Patients-Treated-with-GLP-1-Agonists.html

    GLOBENEWSWIRE
    20 May 2025
    Share Share
    Actimed Therapeutics Names Shaun Claydon CFO
    Actimed Therapeutics Names Shaun Claydon CFO

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067112/0/en/Actimed-Therapeutics-Appoints-Shaun-Claydon-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Actimed Therapeutics Expands Intellectual Property Portfolio
    Actimed Therapeutics Expands Intellectual Property Portfolio

    06 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/06/3021736/0/en/Actimed-Therapeutics-Expands-Intellectual-Property-Portfolio.html

    GLOBENEWSWIRE
    06 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search